WHITTLESEY PHARMACY LIMITED

Company Registration Number:
07309063 (England and Wales)

Unaudited abridged accounts for the year ended 31 July 2024

Period of accounts

Start date: 01 August 2023

End date: 31 July 2024

WHITTLESEY PHARMACY LIMITED

Contents of the Financial Statements

for the Period Ended 31 July 2024

Balance sheet
Notes

WHITTLESEY PHARMACY LIMITED

Balance sheet

As at 31 July 2024


Notes

2024

2023


£

£
Fixed assets
Intangible assets: 3 160,000 170,000
Tangible assets: 4 44,160 48,292
Total fixed assets: 204,160 218,292
Current assets
Stocks: 99,975 98,850
Debtors:   671,606 660,068
Cash at bank and in hand: 118,301 443,630
Total current assets: 889,882 1,202,548
Creditors: amounts falling due within one year:   (191,236) (191,998)
Net current assets (liabilities): 698,646 1,010,550
Total assets less current liabilities: 902,806 1,228,842
Total net assets (liabilities): 902,806 1,228,842
Capital and reserves
Called up share capital: 1,000 1,000
Profit and loss account: 901,806 1,227,842
Shareholders funds: 902,806 1,228,842

The notes form part of these financial statements

WHITTLESEY PHARMACY LIMITED

Balance sheet statements

For the year ending 31 July 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 04 September 2024
and signed on behalf of the board by:

Name: Simon Yacoub
Status: Director

The notes form part of these financial statements

WHITTLESEY PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

WHITTLESEY PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2024

2. Employees

2024 2023
Average number of employees during the period 9 8

WHITTLESEY PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2024

3. Intangible Assets

Total
Cost £
At 01 August 2023 200,000
At 31 July 2024 200,000
Amortisation
At 01 August 2023 30,000
Charge for year 10,000
At 31 July 2024 40,000
Net book value
At 31 July 2024 160,000
At 31 July 2023 170,000

WHITTLESEY PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2024

4. Tangible Assets

Total
Cost £
At 01 August 2023 84,552
Additions 4,800
At 31 July 2024 89,352
Depreciation
At 01 August 2023 36,260
Charge for year 8,932
At 31 July 2024 45,192
Net book value
At 31 July 2024 44,160
At 31 July 2023 48,292

WHITTLESEY PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2024

5. Related party transactions

Name of the related party: No Ordinary locum Agent Limited
Relationship:
Director
Description of the Transaction: "The transaction was the loan of an asset".
£
Balance at 01 August 2023 52,000
Balance at 31 July 2024 52,000
Name of the related party: Clockpad limited
Relationship:
Director
Description of the Transaction: "The transaction was the loan of an asset".
£
Balance at 01 August 2023 240,000
Balance at 31 July 2024 240,000
Name of the related party: Vakani Investments Limited
Relationship:
Director
Description of the Transaction: "The transaction was the loan of an asset".
£
Balance at 01 August 2023 240,000
Balance at 31 July 2024 240,000